509 Matching Annotations
  1. Last 7 days
    1. Hall, V. J., Foulkes, S., Saei, A., Andrews, N., Oguti, B., Charlett, A., Wellington, E., Stowe, J., Gillson, N., Atti, A., Islam, J., Karagiannis, I., Munro, K., Khawam, J., Chand, M. A., Brown, C. S., Ramsay, M., Lopez-Bernal, J., Hopkins, S., … Heeney, J. L. (2021). COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(21)00790-X

    1. Eric Topol. (2021, April 23). Just published @TheLancet: Effect of vaccine in >23,000 health care workers https://t.co/ohy3VyHM3C Dose response: No vaccine 977 infections; 1 dose 71 infections; 2 doses 9 infections (14|8|4 per 10,000 person-days) "can prevent both symptomatic and asymptomatic infection " https://t.co/EybVBFmXrU [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1385729322472730626

    1. Hilda Bastian, PhD. (2021, February 6). Unofficial unnamed AstraZeneca insider says they are doing the interim analysis for the US trial of the Oxford vaccine. AstraZeneca spokesperson says 4-6 weeks till data release. Https://t.co/VUHgbHN02d One is wrong? Or they’ll release only when have FDA minimum follow-up? Https://t.co/LgjfX8AIti [Tweet]. @hildabast. https://twitter.com/hildabast/status/1357862227106095105

    1. Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B. J., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., Clutterbuck, E., Collins, A. M., Cox, T., Darton, T., Dold, C., Douglas, A. D., Duncan, C. J. A., Ewer, K., Flaxman, A., … Group, O. C. V. T. (2021). Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7) (SSRN Scholarly Paper ID 3779160). Social Science Research Network. https://doi.org/10.2139/ssrn.3779160

    1. John Lichfield. (2021, April 10). Weekly French vaccination thread. The French roll-out, still described as “stuttering” or “glacial” in UK media (and even some Fr media) continues to boom. Over 500,000 doses (1st/ 2nd) were given yesterday, a record. Fr should exceed its 10m 1st jabs 15 April target by 2m. 1/12 https://t.co/hhJa8rafCV [Tweet]. @john_lichfield. https://twitter.com/john_lichfield/status/1380807805960130561

    1. Carlos del Rio. (2021, April 7). U.K. variant now dominant form of COVID in US ⁦@CDCDirector⁩ As predicted B.1.1.7 is now the predominant SARS-CoV-2 strain in the US. Let’s remember it is much more transmissible and likely also more severe. Vaccines do cover it. ⁦@ajc⁩ https://t.co/Wc4oaYkxqR [Tweet]. @CarlosdelRio7. https://twitter.com/CarlosdelRio7/status/1379816377356333057

    1. Nicolas Berrod. (2021, April 9). Population majeure vaccinée avec au moins une dose (une seule dose/deux doses), au 8 avril: -Tous âges: 19,3% (12,6%/6,6%) -moins de 75 ans: 13,3% (10,5%/2,8%) -75 ans ou plus: 62,5% (28,2%/34,2%) Les pourcentages sont arrondis. #Covid19 https://t.co/EUsyr9LSo8 [Tweet]. @nicolasberrod. https://twitter.com/nicolasberrod/status/1380586797542039554

    1. Dr Philip Lee. (2021, March 17). It’s been 100 days since the first dose of the SARS2-CoV vaccine was given in the UK, and 24.8 million people have received their first dose since. That is pretty amazing. [Tweet]. @drphiliplee1. https://twitter.com/drphiliplee1/status/1372162781823303681

  2. Apr 2021
    1. Eric Topol on Twitter: “The variants of concern/interest fall into a spectrum of immune evasiveness, w/ B.1.351 being most; B.1.1.7, B.1.429 least. This property pertains to potential for reinfection & some reduction in vaccine efficacy My prelim estimates based on publications/preprints, subject to Δ https://t.co/fQZwBCUEGS” / Twitter. (n.d.). Retrieved April 28, 2021, from https://twitter.com/EricTopol/status/1380203664317456385

    1. Jeremy Faust MD MS (ER physician) on Twitter: “Let’s talk about the background risk of CVST (cerebral venous sinus thrombosis) versus in those who got J&J vaccine. We are going to focus in on women ages 20-50. We are going to compare the same time period and the same disease (CVST). DEEP DIVE🧵 KEY NUMBERS!” / Twitter. (n.d.). Retrieved April 15, 2021, from https://twitter.com/jeremyfaust/status/1382536833863651330

    1. Céline Gounder, MD, ScM, FIDSA. (2021, April 14). With all due respect to @NateSilver538, he is not an expert on the psychology of vaccine confidence. He is a poll aggregator and political pundit. He is not an infectious disease specialist, epidemiologist, vaccinologist, virologist, immunologist, or behavioral scientist. Https://t.co/HBrI6zj9aa [Tweet]. @celinegounder. https://twitter.com/celinegounder/status/1382299663269761024

    1. Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leschinsky, M., Dror, S. K., Bergerzon, G., Gadban, H., Gadban, F., Eliassian, E., Shimron, O., Saleh, L., Ben-Zvi, H., Amichay, D., Ben-Dor, A., … Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals. MedRxiv, 2021.04.06.21254882. https://doi.org/10.1101/2021.04.06.21254882